Pfizer's RSV vaccine paves way for protecting older adults

Pfizer said trials show the vaccine is more than 85% effective in preventing the illness in older adults.

Related Keywords

,Pfizer ,Clinical Research Associates In Nashville ,Clinical Research Associates ,Local News ,News ,Pfizer Vax ,Rsv Vaccine ,Vaccines ,